Connecting Capital and Innovation for Health Advancements
Committed to provide successful diagnosis and better treatments for cancer patients.
We are a biotechnology investment company specialized in In Vitro Diagnostics (IVD) with a focus on improving cancer genetic detection and treatment methods.
Our efforts involve utilizing exosomes, including non-coding RNA and proteins, as well as genomics and organoid technology.
By harnessing these advancements, we aim to provide cancer patients with personalized and precise treatment plans, ultimately leading to better therapeutic outcomes and improved quality of life.
Focus innovation, cooperation and impact
HOW WE DO IT
We are vitro diagnostics experts
We harness the great potential of exosomes (including non-coding RNA, proteins, etc.), genomics, and organoid technology to significantly enhance the accuracy and personalization of cancer detection and treatment.
We weave a network of international cooperation
Through close collaboration with the global academic community and industry partners, we expedite the development and implementation of cutting-edge scientific and technological solutions.
We offer tangible results
Our main objective is to translate research results into clinical applications, providing patients with practical diagnostic and treatment plans, thereby improving patient prognosis.
Driving innovation together against cancer.
News
Would you like to collaborate with us?
Contact for research and investment opportunities.